行情

ANIX

ANIX

Anixa Biosciences Inc
NASDAQ

实时行情|Nasdaq Last Sale

1.550
+0.020
+1.31%
已收盘, 16:00 04/03 EDT
开盘
1.480
昨收
1.530
最高
1.650
最低
1.480
成交量
3.67万
成交额
--
52周最高
5.45
52周最低
1.330
市值
3,256.10万
市盈率(TTM)
-3.3405
分时
5日
1月
3月
1年
5年

分析师评级

2位分析师的综合评级

买入

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

目标价格预测

分析师预测ANIX价格均价为8.25,最高价位8.50,最低价为8.00。

EPS

ANIX 新闻

更多
  • 两年半白干了!百位富豪资产两月缩水超12% LV掌门人每天损失30亿
  • 21世纪经济报道 · 2小时前
  • 印尼股市自3月24日低点累计上涨20% 进入技术性牛市
  • 新浪财经 · 2小时前
  • 华尔街大佬预计标普500最惨或跌至1500点
  • 新浪财经 · 3小时前
  • 波音公司华盛顿州生产基地将无限期停工
  • 中国新闻网 · 3小时前

所属板块

生物技术和医学研究
-0.50%
制药与医学研究
-0.22%

热门股票

代码
价格
涨跌幅

ANIX 简况

Anixa Biosciences, Inc. is a biotechnology company. The Company is developing a cancer immunotherapy program, which leverages chimeric endocrine receptor t-cell (CER-T) technology, and is engaged in developing a diagnostic platform called Cchek, for the early detection of tumor-based cancers. The Cchek liquid biopsy technology is a series of non-invasive blood tests for early detection of solid tumors based on the body's immune response to a malignancy by detecting the presence, absence and quantity of certain immune cells that exist in and around a tumor and that enter the blood stream. This technology enables cancer detection in its earliest stages in efforts to treat patients when the disease is curable. The Company has developed techniques and protocols for measuring the subtle immunological changes that occur in the blood stream during tumor development. Through its protocols, the Company has detected the biomarkers in the peripheral blood of biopsy verified cancer patients.
展开

微牛提供Anixa Biosciences Inc(NASDAQ-ANIX)的股票价格,实时市场报价,专业分析师评级,深度图表和免费的ANIX股票新闻,以帮助您做出投资决策。